# Strategic Feedback — Gemini-3-Flash

**Role:** Journal editor (AER perspective)
**Model:** gemini-3-flash-preview (ai_studio)
**Timestamp:** 2026-03-05T16:49:55.799986
**Route:** Direct Google API + PDF
**Tokens:** 18778 in / 1441 out
**Response SHA256:** 1a0e926d0db11be0

---

To: Board of Editors, American Economic Review
From: Editor
Date: March 6, 2026
Subject: Strategic Assessment of "Does Coverage Create Capacity?"

---

## 1. THE ELEVATOR PITCH

This paper investigates whether a massive expansion in Medicaid eligibility—lifting a 50-year "payment ban" for residential addiction treatment—actually increased the supply of healthcare providers during the opioid crisis. Exploiting the staggered adoption of Section 1115 SUD waivers and a newly released provider-level dataset (T-MSIS), the author finds that while demand for services increased, the treatment workforce did not significantly expand. It is a study of supply-side inelasticity in a market where policy usually focuses exclusively on the demand side (coverage).

**Evaluation:** The paper articulates this well in the first two paragraphs. It frames the issue as a "first-order supply-side question" and correctly identifies the tension between money and infrastructure. 

*The pitch the paper should have (slightly sharpened):*
"We spend billions on insurance coverage to fight the opioid epidemic, but can the healthcare system actually scale to meet that demand? This paper shows that lifting the half-century-old Medicaid 'IMD exclusion' failed to trigger a supply-side response in behavioral health. I demonstrate that in the presence of extreme workforce shortages and regulatory friction, insurance coverage is a necessary but entirely insufficient tool for building treatment capacity."

---

## 2. CONTRIBUTION CLARITY

**One-sentence contribution:** The paper provides the first provider-level, supply-side evaluation of Medicaid SUD waivers, revealing that the "extensive margin" of provider participation is highly inelastic even when major regulatory payment barriers are removed.

- **Differentiation:** It is well-differentiated. While Maclean (2020) and Wen (2022) use discharge data to show demand rose, this paper uses the new T-MSIS spending file to look at the providers themselves. It moves the conversation from "did people get more care?" to "did the industry actually grow?"
- **World vs. Literature:** It frames the question about the WORLD (how to solve the opioid crisis) but leans heavily on a "filling the gap" argument regarding the T-MSIS data.
- **Smart Economist Test:** A reader would explain this as: "It’s a paper showing that insurance doesn't build clinics." That is a strong, intuitive takeaway.
- **What would make it bigger?** The "SUD-specific" decline is the most provocative result. To make this an AER "blockbuster," the author needs to prove *why* those providers declined. Is it reclassification (boring) or did the waiver actually consolidate the market and kill off small specialty providers (fascinating)?

---

## 3. LITERATURE POSITIONING

- **Neighbors:** Alexander and Schnell (2020) on Medicaid fee sensitivity; Maclean et al. (2020) on SUD waivers; Haffajee (2019) on rural capacity.
- **Positioning:** It builds on the demand-side literature by providing the "missing" supply side. It challenges the health workforce literature by suggesting that for certain specialties, the participation margin is essentially zero in the short run.
- **Missing Conversations:** The paper needs to speak more to the **Industrial Organization (IO)** of healthcare. If the waivers required "continuum-of-care" improvements, did this favor large hospital systems over small clinics? The "SUD provider decline" suggests a market structure story that is currently ignored.

---

## 4. NARRATIVE ARC

- **Setup:** The IMD exclusion was a 50-year barrier.
- **Tension:** Policy advocates promised that waiving it would "unlock" capacity.
- **Resolution:** It didn't. Point estimates are noisy; SUD-specific counts actually fell.
- **Implications:** Policy must target workforce and zoning, not just reimbursement.

**Evaluate:** The narrative is "Serviceable." It feels a bit like a "null result" paper trying to justify its existence. To reach the AER, the narrative needs to be more aggressive about the *failure of the price mechanism* in behavioral health.

---

## 5. THE "SO WHAT?" TEST

- **The Fact:** "When Medicaid finally agreed to pay for residential rehab, the number of rehab providers actually went down."
- **Reaction:** People lean in. Why would it go down?
- **Follow-up:** "Was it just paperwork? Or did the big players just swallow the market?"

If the findings are truly null/modest, the paper's value is as a "Cautionary Tale for Technocrats." It is a strong "So What?" because the IMD repeal is a live Congressional debate.

---

## 6. STRUCTURAL SUGGESTIONS

- **Front-loading:** The T-MSIS data description is a bit long. Move the "lazy evaluation" and "Parquet file" details to the appendix. We care that it's big, not how you opened the file.
- **The "SUD Decline" (Figure 1):** This is your most interesting result because it's counter-intuitive. It’s buried in Section 5.1. It should be a centerpiece of the intro.
- **Mechanism:** Section 5.3 is the weakest. It mostly says "entry didn't happen." This needs more meat on *why*—is there data on licensing wait times?

---

## 7. WHAT WOULD MAKE THIS AN AER PAPER?

Currently, the paper is a very high-quality "Evaluation" that might land at *JHE* or *Health Economics*. To make it an **AER** paper, the author must move from **evaluation** to **economic theory**. 

**The Single Most Impactful Piece of Advice:**
Stop treating the negative/null result as a "failure to find significance" and start treating it as a "finding of extreme market friction." Use the T-MSIS data to look at **Market Concentration (HHI)**. If the 1115 waivers included heavy administrative requirements, did they act as a "regulatory tax" that drove out small providers? If you can show the waiver caused **market consolidation** rather than expansion, you have a top-tier paper.

---

### Strategic Assessment

- **Current framing quality:** Adequate
- **Contribution clarity:** Crystal clear
- **Literature positioning:** Well-positioned
- **Narrative arc:** Serviceable
- **AER distance:** Medium (needs a "Market Structure" angle)
- **Single biggest improvement:** Shift from a "null result" policy evaluation to an investigation of why specialty provider counts *declined* (e.g., market consolidation or regulatory capture).